Page 74 - MEMOCiberesp014-ENG

RESEARCH GROUPS
Bioengineering and Telemedicine Group
Programme: Bioengineering and Medical Imaging
Lead Researcher: Del Pozo Guerrero, Francisco Group Members
STAFF MEMBERS: Cobo Sánchez de Rojas, Antonio | Pérez Gandía, Ma Carmen
ASSOCIATED MEMBERS: Cáceres Taladriz, César | De Toledo Heras, Paula | Gómez Aguilera, Enrique José | González Nieto, Daniel | Hernando Pérez, Ma Elena | Maestu Unturbe, Ceferino | Seoane Pascual, Joaquín | Serrano Olmedo, José Javier
CONTRIBUTORS: Caballero Hernández, Ruth | Castellanos, Nazareth | Castillo, Emiliano | Félix González, Nazario | García García, Fernando | García Mendoza, Rubén Antonio | Gutiérrez Díez, Ricardo | Luna Serrano, Marta | Macías Delgado, Ainara | Martínez Sarriegui, Iñaki | Mina Rosales, Alejandra | Moratti, Stephan | Moreno Sánchez, Pedro Antonio | Niso Galán, Julia Guiomar | Piquero Cabañero, Julio Ignacio | Ramos Gómez, Milagros | Rodríguez Herrero, Agustín | Sánchez González, Patricia | Sánchez López de Pablo, Cristina | Serrano Rubio, Álvaro José | Solana Sánchez, Javier
Main lines of research
• Oscillatory activity of the brain: Towards the understanding of the normal cognition and brain disorders; cerebral basis of cognitive function in healthy people and in patients with neurological and psychiatric diseases .
• Advanced biomedical imaging technologies: Neuroimaging biomarkers in aging and dementia; simultaneous EEG- fMRI Recording; functional and structural connectivity .
• Diabetes technologies to apply the available technologies to optimize follow-up and metabolic control of people suffering from diabetes .
• Neurorehabilitation Engineering: to help restore, minimize and/or compensate the alterations, those typically ap- pear on a person after suffering a Traumatic Brain Injury (TBI) or a stroke; Neurorehabilitation processes modeling: dysfunctional and hybrid bionics models; Smart monitoring of cognitive and physical rehabilitation .
• Development of sensors and medical devices based on nanoparticles: hyperthermia induction in living tissues (opti- cal and radiofrequency); biosensors based on nanoparticles for early diagnosis of bacterial diseases .
• Development of biofunctionalized nanomaterials for biomedical applications: Design and manufacture of biocom- patible and stable nanostructures for RMI contrast agents for in vivo early diagnosis of Alzheimer disease; Labeling of human neural precursor cells for in vivo cell tracking in cell replacement therapies against neurodegenerative diseases .
74 CIBER-BBN » Annual report 2014